DRTSW Alpha Tau Medical Ltd. Warrant
$3.84▼ -6.46%
Unknown
Other
Volume 17.2K
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
3.72 - 4.07
% vs 50 MA
24.15%
% vs 200 MA
–%
RSI-14
52.9
MACD Histogram
-0.0600
Beta (1Y vs SPY)
-2.09
Gross Rev
$0
Gross Profit
$0
EBITDA
-$55.05M
COGS
–
Operating Exp
$13.78M
Operating Income
-$13.78M
EBIT
-$13.78M
Pretax Income
-$45.58M
Net Income
-$45.81M
Price & Volume History
Loading chart…
Recent News
Alpha Tau to Participate in September Investor Conferences
GlobeNewswire · Sep 2, 2026 12:00 PM
Alpha Tau Medical Completes Patient Enrollment in Pancreatic Cancer Study
MT Newswires · Aug 31, 2026 12:29 PM
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions
GlobeNewswire · Aug 31, 2026 12:00 PM
Alpha Tau Medical Files for Dual Listing on Tel Aviv Stock Exchange
MT Newswires · Aug 10, 2026 1:25 PM
Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial
Simply Wall St. · Aug 1, 2026 6:16 AM
Alpha Tau Medical Treats First Immunocompromised Patient in Alpha DaRT Study
MT Newswires · Jul 15, 2026 1:48 PM
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center
GlobeNewswire · Jul 15, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DRTSW's money flow as a full page
Social Sentiment
Avg +0.20 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.